Data / Form D filings / Realm Therapeutics plc
Realm Therapeutics plc: Form D filings
Realm Therapeutics plc, a pharmaceuticals company in London, United Kingdom, filed 2 Form D notices with the SEC in 2017. The latest, on October 25, 2017, reports $20.5 million sold of a $20.5 million offering to 8 investors.
Find out what Realm Therapeutics plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- CANNON PLACE, 78 CANNON STREET, London, United Kingdom, EC4N
- Phone
- (484) 321-2700
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- United Kingdom
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1718903
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 25, 2017 | Amendment | $20,500,000 | $20,500,000 | $0 | 8 | Oct 10, 2017 | sec.gov |
| Oct 17, 2017 | New notice | $20,500,000 | $20,500,000 | $0 | 8 | Oct 10, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ivan William Gergel | Director | |
| Daniel William Hegglin | Director | |
| Alex Martin | Executive Officer, Director | |
| Joseph William Birkett | Director | |
| Balkrishan William Gill | Director | |
| Charles Spicer | Director | |
| Matthew William Hammond | Director | |
| Marella Thorell | Executive Officer, Director |
Every Form D from the week of Oct 23, 2017 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Realm Therapeutics plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.